Dcm Advisors, LLC Novavax Inc Transaction History

Dcm Advisors, LLC

  • $188 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$134.56 - $217.97 $240,862 - $390,166
-1,790 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$177.8 - $270.58 $53,340 - $81,174
300 Added 20.13%
1,790 $371,000
Q1 2021

May 17, 2021
BUY
$112.98 - $319.93 $168,340 - $476,695
1,490 New
1,490 $270,000

Others Institutions Holding NVAX

# of Institutions
282
Shares Held
84.7M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $752M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Dcm Advisors, LLC Portfolio

Follow Dcm Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email